日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery

尽管外周血B细胞恢复,但接受利妥昔单抗治疗的B细胞淋巴瘤患者对SARS-CoV-2加强免疫诱导的抗体反应仍受损。

Jurca, Tomaz; Boltezar, Lucka; Orazem, Miha; Komlos, Kristina Fujs; Pohar, Katka; Jevnikar, Sara; Poljak, Mario; Mastnak, Denis Mlakar; Kozjek, Nada Rotovnik; Vratanar, Bor; Ocvirk, Janja; Ihan, Alojz

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab

对于经动脉放射栓塞治疗后完全缓解的晚期肝细胞癌,可采用转化疗法联合阿特珠单抗和贝伐珠单抗进行治疗。

Popovic, Peter; Kalamutova, Ana; Djokic, Mihajlo; Cuderman, Anka; Boltezar, Gasper; Trotovsek, Blaz

Does Thyroid Dysfunction Have a Role in the Etiology of Vocal Fold Edema?

甲状腺功能障碍在声带水肿的病因中是否起作用?

Kravos, Alenka; Gersak, Ksenija; Gaberscek, Simona; Hocevar-Boltezar, Irena

Are there clinically relevant prognostic factors in diffuse large B-cell lymphoma beyond International Prognostic Index?

除了国际预后指数之外,弥漫性大B细胞淋巴瘤还有哪些具有临床意义的预后因素?

Miljkovic, Milica; Dragos, Vita Setrajcic; Gasljevic, Gorana; Novakovic, Srdjan; Boltezar, Lucka; Novakovic, Barbara Jezersek

The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified

程序性细胞死亡蛋白1及其配体在弥漫性大B细胞淋巴瘤(未另行说明)中淋巴瘤细胞和肿瘤免疫细胞上的预后意义

Slak, Teja Cas; Miceska, Simona; Gasljevic, Gorana; Boltezar, Lucka; Kloboves-Prevodnik, Veronika

Long-term outcome of multilayer flow modulator in aortic aneurysms

多层血流调节器治疗主动脉瘤的长期疗效

Pintaric, Karlo; Boltezar, Lucka; Umek, Nejc; Kuhelj, Dimitrij

Ocular adnexal lymphoma - a retrospective study and review of the literature

眼附属器淋巴瘤——一项回顾性研究及文献综述

Boltezar, Lucka; Strbac, Danijela; Pizem, Joze; Hawlina, Gregor

CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

CD56阳性弥漫性大B细胞淋巴瘤:临床、病理和分子特征的综合分析及文献综述

Gasljevic, Gorana; Boltezar, Lucka; Novakovic, Srdjan; Setrajcic-Dragos, Vita; Jezersek-Novakovic, Barbara; Kloboves-Prevodnik, Veronika

Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma

t(14;18)易位断点位点与滤泡性淋巴瘤临床特征的相关性

Panjan, Matej; Boltezar, Lucka; Novakovic, Srdjan; Kokovic, Ira; Jezersek Novakovic, Barbara

Trends in specialized palliative care referrals at an oncology center from 2007 to 2019

2007年至2019年肿瘤中心专科姑息治疗转诊趋势

Boltezar, Lucka; Novakovic, Barbara Jezersek; Moltara, Maja Ebert